FSHR与CYP19A1基因序列变异与控制性卵巢刺激卵巢反应的关系
研究纳入705例接受重组卵泡刺激素卵巢刺激的女性,分析FSHR c.919G>A与CYP19A1 c.*19C>T序列变异与COS反应的关系。结果提示FSHR 307位点Ala/Ala基因型者基线FSH较高且更易出现低卵巢反应,CYP19A1 TT基因型者获卵数较少,两变异联合分析显示对低卵巢反应风险有协同效应。
要点
- FSHR 307位点Ala/Ala基因型者基线FSH水平较高,更易出现低卵巢反应。
- CYP19A1 c.*19C>T TT基因型者卵巢刺激后获卵数较少。
- 两序列变异联合分析显示对低卵巢反应风险具有协同效应。
核心结论
- 结果支持参与雌激素合成的基因(尤其是FSHR和CYP19A1)序列变异与COS结局存在关联。
研究设计与样本
- 遗传关联研究,采用单基因及联合分析,纳入705例接受重组卵泡刺激素卵巢刺激的女性。
- 研究场所为学术研究机构医院,干预包括外周血提取、DNA纯化及FSHR c.919G>A(rs6165,p.Thr307Ala)和CYP19A1 c.*19C>T(rs10046)序列变异分析。
主要发现
- FSHR 307位点Ala/Ala基因型女性较其他基因型基线FSH水平更高,且更易出现低卵巢反应。
- CYP19A1 TT基因型女性卵巢刺激后获卵数更少。
- 两序列变异联合分析显示对低卵巢反应风险具有协同效应。
关键数值与推荐
- 主要结局指标包括FSHR c.919G>A和CYP19A1 c.*19C>T序列变异基因型及与COS反应相关的临床参数(获卵数、激素水平、外源性FSH剂量)。
- 统计分析使用SPSS17.0软件进行单基因统计分析和联合统计分析。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether sequence variants within the FSHR and CYP19A1 genes are related to the ovarian response to controlled ovarian stimulation (COS). DESIGN: Genetic association study using both single-gene and combined analyses of women with sequence variants undergoing in vitro fertilization treatment. SETTING: Academic research institute hospital. PATIENT(S): Seven hundred and five women undergoing ovarian stimulation with recombinant follicle-stimulating hormone (FSH). INTERVENTION(S): Peripheral blood extraction, DNA purification, and FSHR c.919G>A (rs6165, p.Thr307Ala) and CYP19A1 c.*19C>T (rs10046) sequence variants analyses. MAIN OUTCOME MEASURE(S): Single-gene statistical analysis and combined statistical analysis with the SPSS17.0 software; FSHR c.919G>A and CYP19A1 c.*19C>T sequence variant genotypes and clinical parameters related to the COS response as oocyte retrieval and hormone levels, doses of exogenous FSH. RESULT(S): Women with genotype Ala/Ala at FSHR position 307 had higher basal levels of FSH and were more likely to have a low ovarian response compared with other genotypes. Women with genotype TT at CYP19A1 yielded fewer oocytes after ovarian stimulation. The combined analysis of these two sequence variants revealed that these two single-nucleotide variants have a synergistic effect in conferring the risk of a low ovarian response. CONCLUSION(S): Our results support an association of sequence variants in the genes that participate in estrogen synthesis, notably the FSHR and CYP19A1 genes, with the outcome of COS.
引用
- Song D, Huang XL, Hong L, et al. Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation. Fertil Steril. 2019. PMID: 31371045. doi:10.1016/j.fertnstert.2019.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。